
South Korea’s antitrust regulator said Monday it has given a warning against Lee Jae-yong, Samsung Group’s de facto leader, over allegations that he has submitted falsified data about the group’s affiliates.
The chiefs of large business groups are required to submit to the Fair Trade Commission (KFTC) every year details about affiliates governed by them and their family members and information of executives and shareholders of corporate units.
In 2018-2019, Lee, vice chairman of Samsung Electronics Co., submitted documents in which companies governed by the group’s outside directors were omitted from Samsung affiliates, according to the KFTC.
The KFTC said the omission did not affect its move to designate Samsung as a large business group on its antitrust watch list. But due to the falsified data, it took more than a year to put affected companies under the wing of Samsung’s affiliates.
Large business groups with assets exceeding 5 trillion won (US$4 billion) are required to publicly file their business information, and those with 10 trillion won in assets or more are banned from making equity investments among affiliates or offering loan guarantees to each other.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
EU Clears ADNOC’s $16.3 Billion Acquisition of Covestro
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas